MedTrace Logo

Vascular Physician Offer and Report (VAPOR) Trial

NCT02220686 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 156

Last updated 2017-07-27

No results posted yet for this study

Summary

The purpose of the study is to see if vascular physicians (your provider) using a combination of proven smoking cessation tools in an organized way can help vascular patients quit smoking better than usual.

The doctors where you are being treated have been chosen to either provide:

the combination therapy of giving you advice, considering prescribing medications to help you quit smoking, and referring you to a phone quitline, or to continue their usual smoking cessation practices (which may include all, some, or none of the treatments above).

Conditions

  • Peripheral Artery Disease (PAD)

Interventions

BEHAVIORAL

Offer and Report Protocol

Physician advice to stop smoking, referral to state Quitline, and physician considers prescribing nicotine replacement therapy.

Sponsors & Collaborators

  • Society for Vascular Surgery

    collaborator OTHER

  • Dartmouth-Hitchcock Medical Center

    lead OTHER

Principal Investigators

  • Philip Goodney, MD, MS · Dartmouth-Hitchcock Medical Center

  • Alik Farber, MD · Boston Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02220686 on ClinicalTrials.gov